
|Articles|September 15, 2014
- BioPharm International-09-15-2014
- Volume 2014 eBook
- Issue 3
Biopharma Contract Manufacturing Prices Go Up—and Down
Author(s)William Downey
A dynamic market, industry consolidation, and demand fluctuations lead to a mixed picture of pricing results.
Advertisement
A dynamic market, industry consolidation, and demand fluctuations lead to a mixed picture of pricing results.
from BioPharm International’s 2014 Outsourcing Strategies eBook.
View other articles in the
.
Articles in this issue
over 11 years ago
Ensuring Sound Bioanalytical Methods Transferover 11 years ago
CMOs Gear Up for Biologics Manufacturing Challengesover 11 years ago
Weighing Clinical Trial Outsourcing Optionsover 11 years ago
Outsourcing Trends in Biopharmaceutical ManufacturingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
CDC Revises Childhood Immunization Schedule, Shifting Demand Dynamics
2
Industry Outlook 2026: Biopharma Braces for Economic Upheaval While Eyeing AI-Driven Transformation (Part 1)
3
New AI Oncology Alliance Highlights Industry Push for Scalable Genomics
4
What Are the Benefits of Single-Use in CGT Manufacturing?
5





